Advertisement

Infection in Hospitals

  • R. Baker
  • A. Zumla
  • B. S. Peters
Part of the Developments in Nuclear Medicine book series (DNUM, volume 31)

Abstract

Infectious Disease is a clinical speciality which crosses the boundaries of all other medical disciplines. Hippocrates and Galen were able to diagnose typhoid and malaria by the characteristic pattern of their fevers. Most infectious and inflammatory conditions however do not have such diagnostic clinical features. The accurate localisation and characterisation of inflammation and infection has emerged as one of the greatest challenges of modern medicine. This challenge is increased by the advent of large numbers of patients with profound immunosuppression, either due to AIDS or iatrogenically during chemotherapy. Immunosuppressed patients may have severe infection without exhibiting any of the classical signs and symptoms. Furthermore the introduction of an ever increasing range of invasive procedures has led to a greater incidence and diversity of infective sequelae.

Keywords

Spinal Cord Injury Urinary Tract Infection Infective Endocarditis Visceral Leishmaniasis Graft Versus Host Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lichtman SM. Physiological aspects of aging. Implications for the treatment of cancer. Drugs Aging [1995];7[3]: 212–225.PubMedCrossRefGoogle Scholar
  2. 2.
    Norman DC, Toledo SD. Infections in elderly persons. An altered clinical presentation. [Review]. Clin Geriatric Med [1992];8(4): 713–719.Google Scholar
  3. 3.
    Evans JG. General medicine and geriatrics, where is the difference? The example of infective disease. Schweiz Med Wochenschr [1995];125[40]: 1847–1854.PubMedGoogle Scholar
  4. 4.
    Saltzman RL, Peterson PK. Immunodeficiency of the elderly. [Review]. Reviews of Infectious Diseases [1987];9[6]: 1127–1139.PubMedCrossRefGoogle Scholar
  5. 5.
    Ben YA, Weksler ME. Host resistance and the immune system. [Review]. Clin Geriatric Med [1992];8[4]: 701–711.Google Scholar
  6. 6.
    Rummans TA, Evans JM, Krahn LE, Fleming KC. Delirium in elderly patients: evaluation and management. Mayo Clin Proc [1995];70[10]: 989–998.PubMedCrossRefGoogle Scholar
  7. 7.
    Melchior H. [Disorders of bladder function in the elderly]. Urologe A [1995];34[4]: 329–333.PubMedGoogle Scholar
  8. 8.
    Lew J, Glass R, Gangarosa R, et al. Diarrheal deaths in the United States, 1979 through 1987. JAMA [1991];265: 3280–3284.PubMedCrossRefGoogle Scholar
  9. 9.
    Woodhead M. Pneumonia in the elderly. J Antimicrob Chemother [1994]Google Scholar
  10. 10.
    Bentley DW. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment. [Review]. Gerontology [1984];30[5]: 297–307.PubMedCrossRefGoogle Scholar
  11. 11.
    Heuser MD, Case LD, Ettinger WH. Mortality in intensive care patients with respiratory disease. Is age important? Arch Intern Med [1992];152[8]: 1683–1688.PubMedCrossRefGoogle Scholar
  12. 12.
    Yoshikawa TT, Norman DC. Infection control in long-term care. Clin Geriatr Med [1995];11[3]: 467–480.PubMedGoogle Scholar
  13. 13.
    Leibovici L. Bacteraemia in the very old. Features and treatment. Drugs Aging [1995];6[6]: 456–464.PubMedCrossRefGoogle Scholar
  14. 14.
    Gransden WR, Eykyn SJ, Phillips I. Septicaemia in the newborn and elderly. J Antimicrob Chemother [1994]Google Scholar
  15. 15.
    Meyers BR, Sherman E, Mendelson MH, et al. Bloodstream infections in the elderly [see comments]. Am J Med [1989];86[4]: 379–384.PubMedCrossRefGoogle Scholar
  16. 16.
    Richardson JP. Bacteremia in the elderly. [Review]. J Gen Intern Med [1993];8[2]: 89–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Matthews D. The prevention and diagnosis of infective endocarditis. The primary care provider’s role. Nurse Pract [1994];19[8]: 53–60.PubMedCrossRefGoogle Scholar
  18. 18.
    Norman DC, Yoshikawa TT. Infections of the bone, joint, and bursa. Clin Geriatr Med [1994];10[4]: 703–718.PubMedGoogle Scholar
  19. 19.
    Rosenberg AS, Brown AE. Infection in the cancer patient. [Review]. Disease A Month [1993];39[7]: 505–569.PubMedGoogle Scholar
  20. 20.
    Krishnasamy M. Oral problems in advanced cancer. Eur J Cancer Care Engl [1995];4[4]: 173–177.PubMedCrossRefGoogle Scholar
  21. 21.
    Casey KR. Neoplastic mimics of pneumonia. Semin Respir Infect [1995];10[3]: 131–142.PubMedGoogle Scholar
  22. 22.
    Binet I, Schifferli JA. [Infectious risk factors with special attention to elderly patients.] Schweiz Med Wochenschr [1994];124[49]: 2226–2228.PubMedGoogle Scholar
  23. 23.
    Das PK, Chhotaray MK, Rath RN, Kar S, Das B, Parida B. Infection in haematological malignancies. J Indian Med Assoc [1994];92[10]: 328–330.PubMedGoogle Scholar
  24. 24.
    Farr BM. Vascular catheter related infections in cancer patients. Surg Oncol Clin N Am [1995];4[3]: 493–503.PubMedGoogle Scholar
  25. 25.
    Immunosuppressive drugs and their complications. Drug Ther Bull [1994];32[9]: 66–70.Google Scholar
  26. 26.
    Devine SM, Wingard JR. Viral infections in severely immunocompromised cancer patients. Support Care Cancer [1994];2[6]: 355–368.PubMedCrossRefGoogle Scholar
  27. 27.
    Benedict S, Colagreco J. Fungal infections associated with malignancies, treatments, and AIDS. Cancer Nurs [1994];17[5]: 411–417.PubMedGoogle Scholar
  28. 28.
    Wenzel RP. Preoperative antibiotic prophylaxis [editorial; comment]. N Engl J Med [1992];326[5]: 337–339.PubMedCrossRefGoogle Scholar
  29. 29.
    Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol [1985];121[2]: 159–167.PubMedGoogle Scholar
  30. 30.
    Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G. Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial. Surgery [1992];112[1]: 24–31.PubMedGoogle Scholar
  31. 31.
    Salemi C, Morgan J, Padilla S, Morissey R. Association between severity of illness and mortality from nosocomial infection. Am J Infect Control [1995];23[3]: 188–193.PubMedCrossRefGoogle Scholar
  32. 32.
    Colling J, McCreedy M, Owen T. Urinary tract infection rates among incontinent nursing home and community dwelling elderly. Urol Nurs [1994];14[3]: 117–119.PubMedGoogle Scholar
  33. 33.
    Andrews CP, Coalson JJ, Smith JD, Johanson WJ. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest [1981];80[3]: 254–258.PubMedCrossRefGoogle Scholar
  34. 34.
    Bassin AS, Niederman MS. New approaches to prevention and treatment of nosocomial pneumonia. Semin Thorac Cardiovasc Surg [1995];7[2]: 70–77.PubMedGoogle Scholar
  35. 35.
    Von RK, Harris JR. Pulmonary dysfunction related to immobility in the trauma patient. Aacn Clin Issues [1995];6[2]: 212–228.Google Scholar
  36. 36.
    Napolitano LM, Campbell C. Polymicrobial sepsis following trauma inhibits interleukin-10 secretion and lymphocyte proliferation. J Trauma [1995];39[1]: 104–110.PubMedCrossRefGoogle Scholar
  37. 37.
    O’Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg [1995];222[4]: 482–490.Google Scholar
  38. 38.
    Haum A, Perbix W, Hack HJ, Stark GB, Spilker G, Doehn M. Alcohol and drug abuse in burn injuries. Burns [1995];21[3]: 194–199.PubMedCrossRefGoogle Scholar
  39. 39.
    Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther [1995];75[6]: 526–538.PubMedGoogle Scholar
  40. 40.
    Griswold JA. White blood cell response to burn injury. Semin Nephrol [1993];13[4]: 409–415.PubMedGoogle Scholar
  41. 41.
    Heideman M, Bengtsson A. The immunologic response to thermal injury. World J Surg [1992];16[1]: 53–56.PubMedCrossRefGoogle Scholar
  42. 42.
    Pruitt BJ, McManus AT. The changing epidemiology of infection in burn patients. World J Surg [1992];16[1]: 57–67.PubMedCrossRefGoogle Scholar
  43. 43.
    Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current treatment of severely burned patients. Ann Surg [1996];223[1]: 14–25.PubMedCrossRefGoogle Scholar
  44. 44.
    Levine NS, Salisbury RE. Infection in the burned upper extremity. Major Problems Clin Surg [1976];19[47]: 47–62.Google Scholar
  45. 45.
    Winkelman MD, Galloway PG. Central nervous system complications of thermal burns. A postmortem study of 139 patients. Medicine [1992];71[5]: 271–283.PubMedGoogle Scholar
  46. 46.
    Yakuboff KP, Kurtzman LC, Stern PJ. Acute management of thermal and electrical burns of the upper extremity. [Review.] Orth Clin N Am [1992];23[1]: 161–169.Google Scholar
  47. 47.
    De Vivo MJ, Ivie C3. Life expectancy of ventilator-dependent persons with spinal cord injuries. Chest [1995];108[l]: 226–232.CrossRefGoogle Scholar
  48. 48.
    Komura T, Yamasaki M, Muraki S, Seki K. Characteristics of the health conditions of old patients with spinal cord injury. J Hem Ergol Tokyo [1994];23[2]: 151–157.Google Scholar
  49. 49.
    Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehab [1995];76[3]: 272–280.CrossRefGoogle Scholar
  50. 50.
    Hammond MC, Bozzacco VA, Stiens SA, Buhrer R, Lyman P. Pressure ulcer incidence on a spinal cord injury unit. Adv Wound Care [1994];7[6]: 57–60.PubMedGoogle Scholar
  51. 51.
    McBride DQ, Rodts GE. Intensive care of patients with spinal trauma. Neurosurg Clin N Am [1994];5[4]: 755–766.PubMedGoogle Scholar
  52. 52.
    Jang TN, Fung CP. Treatment of pyogenic splenic abscess: nonsurgical procedures. J Formos Med Assoc [1995];94[6]: 309–312.PubMedGoogle Scholar
  53. 53.
    Colachis S, Otis SM. Occurrence of fever associated with thermoregulatory dysfunction after acute traumatic spinal cord injury. Am J Phys Med Rehab [1995];74[2]: 114–119.Google Scholar
  54. 54.
    Shaw BJ, Martin DJ, Marquez JM, et al. Venous bypass in clinical liver transplantation. Ann Surg [1984];200[4]: 524–534.PubMedCrossRefGoogle Scholar
  55. 55.
    Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schroter GP. Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med [1981];305[5]: 266–269.PubMedCrossRefGoogle Scholar
  56. 56.
    Kibbler CC. Infections in liver transplantations: risk factors and strategies for prevention. J Hosp Infect [1995]Google Scholar
  57. 57.
    Tolkoff RN, Rubin RH. The infectious disease problems of the diabetic renal transplant recipient. Infect Dis Clin North Am [1995];9[1]: 117–130.Google Scholar
  58. 58.
    Avery RK, Longworth DL. Viral pulmonary infections in thoracic and cardiovascular surgery. Semin Thorac Cardiovasc Surg [1995];7[2]: 88–94.PubMedGoogle Scholar
  59. 59.
    Keenan RJ, Zeevi A. Immunologic consequences of transplantation. Chest Surg Clin N Am [1995];5[1]: 107–120.PubMedGoogle Scholar
  60. 60.
    Mitchell DM, Miller RF. AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals. [Review]. Thorax [1995];50[3]: 294–302.PubMedCrossRefGoogle Scholar
  61. 61.
    Garay SM, Belenko M, Fazzini E, Schinella R. Pulmonary manifestations of Kaposi’s sarcoma. Chest [1987];91[1]: 39–43.PubMedCrossRefGoogle Scholar
  62. 62.
    Margulis S, Honig C, Soave R, et al. Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med [1986];105: 207.PubMedGoogle Scholar
  63. 63.
    Peters B, Carlin E, Weston R, Loveless S, Sweney J, Weber J, Main J. Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection. Drug Safety [1994];[10]: 439–454.PubMedCrossRefGoogle Scholar
  64. 64.
    Chaisson RE, Griffin DE. Progressive multifocal leucoencephalopathy in AIDS [clinical conference]. JAMA [1990];264[l]: 79–82.PubMedCrossRefGoogle Scholar
  65. 65.
    Hollander H, Stringari S. Human immunodeficiency virus-associated meningitis. Clinical course and correlations. Am J Med [1987];83[5]: 813–816.PubMedCrossRefGoogle Scholar
  66. 66.
    Margolis TP, Lowder CY, Holland GN, et al. Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol [1991];112[2]: 119–131.PubMedGoogle Scholar
  67. 67.
    Wasserman L, Haghighi P. Optic and ophthalmic pneumocystosis in acquired immunodeficiency syndrome. Report of a case and review of the literature. [Review]. Arch Pathol Lab Med [1992]; 116[5]: 500–503.PubMedGoogle Scholar
  68. 68.
    Koehler J, Le Boit P, Egbert B, et al. Cutaneous vascular lesions and disseminated cat-scratch disease in patients with AIDS and AIDS-related complex. Ann Intern Med [1988];109: 449–455.PubMedGoogle Scholar
  69. 69.
    Rao TK, Filippone EJ, Nicastri AD, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med [1984];310[l 1]: 669–673.PubMedCrossRefGoogle Scholar
  70. 70.
    Eber B, Rabenau H, Berger A, et al. Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany. Int J Med Microbiol Virol Parasitol Infect Dis [1995];282[1]: 102–112.Google Scholar
  71. 71.
    Crane LR, Levine DP, Zervos MJ, Commings G. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors and empiric therapy. Rev Infect Dis [1986];8[3]: 364–373.PubMedCrossRefGoogle Scholar
  72. 72.
    Henriksen BM, Albrektsen SB, Simper LB, Gutschik E. Soft tissue infections from drug abuse. A clinical and microbiological review of 145 cases. Acta Orthop Scand [1994];65[6]: 625–628.PubMedGoogle Scholar
  73. 73.
    Hemingway DM, Balfour AE, McCartney AC, Leiberman DP. Streptococcus milleri and complex groin abscesses in intravenous drug abusers. Scottish Med J [1992];37[4]: 116–117.Google Scholar
  74. 74.
    Wallace JR, Lucas CE, Ledgerwood AM. Social, economic, and surgical anatomy of a drug-related abscess. Am Surgeon [1986];52[7]: 398–401.PubMedGoogle Scholar
  75. 75.
    Wald ER. Risk factors for osteomyelitis. [Review]. Am J Med [1985];78[6B]: 206–212.PubMedCrossRefGoogle Scholar
  76. 76.
    Bosch U. [Compartment syndrome of the pelvis]. [German]. Unfallchirurg [1991];94[5]: 244–248.PubMedGoogle Scholar
  77. 77.
    Komshian SV, Tablan OC, Palutke W, Reyes MP. Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. Rev Infect Dis [1990];12[4]: 693–702.PubMedCrossRefGoogle Scholar
  78. 78.
    Weisse AB, Heller DR, Schimenti RJ, Montgomery RL, Kapila R. The febrile parenteral drug user: a prospective study in 121 patients. Am J Med [1993];94[3]: 274–280.PubMedCrossRefGoogle Scholar
  79. 79.
    Nallathambi MN, Ivatury RR, Lankin DH, Wapnir IL, Stahl WM. Pyogenic splenic abscess in intravenous drug addiction. Am Surgeon [1987];53[6]: 342–346.PubMedGoogle Scholar
  80. 80.
    Fry DE, Richardson JD, Flint LM. Occult splenic abscess: an unrecognized complication of heroin abuse. Surgery [1978];84[5]: 650–654.PubMedGoogle Scholar
  81. 81.
    Frater RW. Surgical management of endocarditis in drug addicts and long-term results. J Cardiac Surg [1990];5[l]:63–67.CrossRefGoogle Scholar
  82. 82.
    O’Donnell AE, Selig J, Aravamuthan M, Richardson MS. Pulmonary complications associated with illicit drug use. Chest [1995];108[2]: 460–463.CrossRefGoogle Scholar
  83. 83.
    Brown LJ, Hickson MJ, Ajuluchukwu DC, Bailey J. Medical disorders in a cohort of New York city drug abusers: much more than HIV disease. J Addict Dis [1993];12[4]: 11–27.PubMedCrossRefGoogle Scholar
  84. 84.
    Perper JA, Van TD. Respiratory complications of cocaine abuse. Recent Dev Alcohol [1992];10[363]: 363–377.PubMedGoogle Scholar
  85. 85.
    Sherman KE, Lewey SM, Goodman ZD. Talc in the liver of patients with chronic hepatitis C infection. Am J Gastroenterol [1995];90[12]: 2164–2166.PubMedGoogle Scholar
  86. 86.
    Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later [see comments]. Ann Intern Med [1993];119[10]: 1017–1028.PubMedGoogle Scholar
  87. 87.
    Fortenberry JD. Adolescent substance use and sexually transmitted disease risk: a review. J Adolesc Health [1995];16[4]: 304–308.PubMedCrossRefGoogle Scholar
  88. 88.
    Petersdorf R, Beeson P. Fever of unexplained origin: Report of 100 cases. Medicine [1961];40: 1.PubMedCrossRefGoogle Scholar
  89. 89.
    Durack D, Street A. Fever of unknown origin — re-examined and redefined. In: Remington J, Swartz M, ed. Current Clinical Topics of Infectious Diseases. St. Louis, Mo: Mosby-Year Book, Inc, 1991:35.Google Scholar
  90. 90.
    Wong SY, Lam MS. Pyrexia of unknown origin-approach to management. Singapore Med J [1995];36[2]: 204–208.PubMedGoogle Scholar
  91. 91.
    Miralies P, Moreno S, Perez TM, Cosin J, Diaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis [1995];20[4]: 872–875.CrossRefGoogle Scholar
  92. 92.
    Rothman DL, Schwartz SI, Adams JT. Diagnostic laparotomy for fever or abdominal pain of unknown origin. Am J Surg [1977];133[3]: 273–275.PubMedCrossRefGoogle Scholar
  93. 93.
    de Kleijn E, van der Meer J. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth J Med [1995];47[2]: 54–60.PubMedCrossRefGoogle Scholar
  94. 94.
    Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med [1992];152[1]: 51–55.PubMedCrossRefGoogle Scholar
  95. 95.
    Navin TR, Juranek DD. Cryptosporidiosis: clinical, epidemiologic, and parasitologic review. [Review]. Rev Infect Dis [1984];6[3]: 313–327.PubMedCrossRefGoogle Scholar
  96. 96.
    Gushulak BD, St JR, Jeychandran T, Coksedge W. Human plague in India, August-October, 1994. Can Commun Dis Rep [1994];20[20]: 181–183.PubMedGoogle Scholar
  97. 97.
    Warrell DA, Warrell MJ. Human rabies: a continuing challenge in the tropical world. Schweiz Med Wochenschr [1995];125[18]: 879–885.PubMedGoogle Scholar
  98. 98.
    Langley JM, Marrie TJ, Covert A, Waag DM, Williams JC. Poker players’ pneumonia. An urban outbreak of Q fever following exposure to a parturient cat. N Engl J Med [1988];319[6]: 354–356.PubMedCrossRefGoogle Scholar
  99. 99.
    Wolfe MS. Diseases of travellers. Clin Symposia [1984];36[2]: 2–32.Google Scholar
  100. 100.
    Doherty JF, Grant AD, Bryceson AD. Fever as the presenting complaint of travellers returning from the tropics. QJM [1995];88[4]: 277–281.PubMedGoogle Scholar
  101. 101.
    Bradley D, Warhurst D, Blaze M, Smith V. Malaria imported into the United Kingdom in 1992 and 1993. Commun Dis Reo Cdr Rev [1994];4[1])Google Scholar
  102. 102.
    Humar A, Keystone J. Evaluating fevers in travellers returning from tropical countries. Br Med J [1996];312[7036]: 953–956.CrossRefGoogle Scholar
  103. 103.
    Maclean J, Lalonde R, Ward B. Fever from the tropics. In: Travel Medicine Advisor. 1994: 27.1–27.14 vol 5.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • R. Baker
  • A. Zumla
  • B. S. Peters

There are no affiliations available

Personalised recommendations